Benjamin Arancibia

Benjamin Arancibia serves as the Director of Data Science at GSK, where he leverages over 11 years of experience in technology-driven solutions to enhance the company’s analytical capabilities across various sectors, including public health, private industry, and social initiatives. In his current role, Benjamin is at the forefront of decision-making processes, utilizing predictive modeling to inform strategic initiatives and optimize clinical trial development pipelines. His expertise in statistical methodology productionization allows him to identify and implement innovative statistical methods that enhance the robustness and efficiency of GSK's research efforts.

A key focus of Benjamin’s work is the adoption of R programming within the organization, where he champions the integration of advanced analytical tools to streamline data analysis and improve research outcomes. His commitment to talent development is evident as he oversees comprehensive training programs designed to elevate the skills and capabilities of the data science team within GSK Biostatistics. By fostering a culture of continuous learning and professional growth, Benjamin ensures that his team is equipped to tackle complex analytical challenges and contribute to high-stakes projects that are often scrutinized by C-suite executives and board members.

Benjamin's multifaceted skill set encompasses data science, GIS, statistics, data mining, and management consulting, making him a pivotal figure in driving GSK's data-driven decision-making processes. His ability to produce high-quality analytical work not only supports the organization’s strategic objectives but also positions GSK as a leader in leveraging data science for innovative healthcare solutions. Through his leadership, Benjamin continues to shape the future of data science at GSK, ensuring that the organization remains at the cutting edge of research and development in the pharmaceutical industry.